Clinical Trial

An Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy

Study acronym: CELSIO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial is intended for patients awaiting an interventional bronchoscopy procedure where the use of a cryocatheter is considered. This type of catheter is already used in clinical practice for the treatment of certain types of bronchial obstructions, including tumors, granulomas, and for foreign bodies extractions. This catheter uses extremely cold temperatures offering unique advantages compared to heat-based technologies. Different types of reusable and single-use cryocatheters are actually available on the market. This type of device requires the use of expensive and bulky consoles operating with heavy gas tanks, resulting in high maintenance costs. A Quebec, Canada based company has developed a cryocatheter that combines procedural efficacy with practical considerations in mind. The Celsio cryocatheter operates without a console and is designed to accommodate the bronchscopist through the different types of cryogenic procedures. This study aims to generate meaningful, real-world evidence without interfering with standard clinical care. The collected data will serve to characterize the device's performance profile, identify best practices for its use, and provide data for the design of future prospective comparative studies.
Trial Details
NCT Number NCT07539701
Lead Sponsor Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Conditions Lung Cancer (Diagnosis), Interstitial Lung Disease (ILD)
Enrollment 30 participants
Start Date 2026-03-23
Primary Completion 2027-03-23 (estimated)
Study Completion 2028-03-23 (estimated)
Updated on ClinicalTrials.gov 2026-04-20